Carbon Monoxide-Releasing Molecule-A1 Inhibits Th1/Th17 and Stimulates Th2 Differentiation In vitro

Scandinavian Journal of Immunology

Volumn 80, Issue 2, 2014, Pages 95-100

  Nikolic, I ^a   Vujicic, M ^a   Stojanovic, I ^a   Stosic Grujicic, S ^a   Saksida, T ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE A1; CD28 ANTIBODY; CD3 ANTIBODY; CELL ANTIBODY; GAMMA INTERFERON; HEME OXYGENASE 1; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; ORGANOBORON DERIVATIVE; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; LYMPH NODE CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; ANTIBODIES; ANTIGENS, CD28; ANTIGENS, CD3; APOPTOSIS; BORANES; CARBON MONOXIDE; CARBONATES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; GATA3 TRANSCRIPTION FACTOR; HEME OXYGENASE-1; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; T-BOX DOMAIN PROTEINS; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84903906605     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12189     Document Type: Article

References (25)

1. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006;86:583-650.
2. Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 2010;9:728-43.
3. Yachie A, Niida Y, Wada T et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999;103:129-35.
4. Pae HO, Oh GS, Choi BM et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 2004;172:4744-51.
5. + T cells and protect from type 1 diabetes. Eur J Immunol 2013;43:209-18.
6. Moterllini R. Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities. Biochem Soc Trans 2007;35:1142-6.
7. Motterlini R, Sawle P, Hammad J et al. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J 2005;19:284-6.
8. Fagone P, Mangano K, Quattrocchi C et al. Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1. Clin Exp Immunol 2011;163:368-74.
9. Nikolic I, Saksida T, Mangano K et al. Pharmacological application of CO ameliorates islet-directed autoimmunity in mice via anti-inflammatory and anti-apoptotic effects. Diabetologia 2014; 57:980-90.
10. Rautajoki KJ, Kylaniemi MK, Raghav SK, Rao K, Lahesmaa R. An insight into molecular mechanisms of human T helper cell differentiation. Ann Med 2008;40:322-35.
11. + T cell lineage differentiation. Immunity 2009;30:646-55.
12. + T-cell subsets. Immunol Rev 2013;252:5-11.
13. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997;89:587-96.
14. Chen Z, Laurence A, O'Shea JJ. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin Immunol 2007;19:400-8.
15. Althaus M, Fronius M, Buchäckert Y et al. Carbon monoxide rapidly impairs alveolar fluid clearance by inhibiting epithelial sodium channels. Am J Respir Cell Mol Biol 2009;41:639-50.
16. Song R, Mahidhara RS, Zhou Z et al. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol 2004;172:1220-6.
17. Alegre ML, Frauwirth KA, Thompson CB. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 2001;1:220-8.
18. Rémy S, Blancou P, Tesson L et al. Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity. J Immunol 2009;182:1877-84.
19. Otterbein L, Bach F, Alam J et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000;6:422-8.
20. + Tc17 cells with reduced cytotoxic activity. Eur J Immunol 2009;39:1716-25.
21. Billiau A, Matthys P. Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev 2009;20:97-113.
22. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010;129:311-21.
23. + T cell responses. Front Physiol 2013;4:206.
24. Zhang Y, Zhang L, Wu J, Di C, Xia Z. Heme oxygenase-1 exerts a protective role in ovalbumin-induced neutrophilic airway inflammation by inhibiting Th17 cell-mediated immune response. J Biol Chem 2013;288:34612-26.
25. + T helper cells. Cell 2006;126:1121-33.